Liver biopsy in patients with chronic hepatitis C virus infection: Experience in a district hospital;Biopsia hepática en pacientes con infección crónica por el VHC: Experiencia de un hospital comarcal

Gastroenterologia y Hepatologia

Volumn 29, Issue 8, 2006, Pages 443-446

  Ubina Aznar E ^a,b   Mendez Sanchez I ^a   Rivera Irigoin, R ^a   Vera Rivero, F ^a   Fernandez Moreno N ^a   Garcia Fernandez G ^a   Navarro Jarabo, J M ^a   Fernandez Perez F ^a   Moreno Mejias P ^a   Perez Aisa A ^a   Sanchez Cantos A ^a  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; EXPERIENTIAL LEARNING; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; NON INVASIVE PROCEDURE;

EID: 33750361155     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13092562     Document Type: Article

References (13)

1. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology. 2002;36:S152-60.
2. Desmet VJ, Gerber MA, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-20.
3. Gebo KA, Herlong HF, Tobenson MS, Jenckes NW, Chader G, Chanem KG, et al. Role of liver biopsy in management of chronic hepatitis C: a systemic review. Hepatology. 2002;36:S161-72.
4. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
5. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39:239-44.
6. Bedossa P, Dargére D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449-57.
7. Soloway RD, Baggenstross AH, Schoenfield LJ, et al. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis. 1971;16:1082-7.
8. National Institutes of Health. Consensus Development Conference Panel statement. Management of hepatitis C. Hepatology. 1997;26:S5-10.
9. Consensus Statement. EASL International Consensus Conference Statement Management of hepatitis C: 2002-June 10-12, 2002. Hepatology. 2002;36 Suppl 1:S3-20.
10. French Consensus Conference. Treatment of hepatitis C. Recommendations. Paris, February 2002. Med Sci. 2002;18:375-82.
11. EASL International Consensus Conference on Hepatitis C. Paris, 26-27, February 1999. Consensus statement. J Hepatol. 1999;31 Suppl 1:3-8.
12. National Institutes of Health Consensus Development Conference Statement. Menagement of Hepatitis C: 2002-June 10-12, 2002. Hepatology. 2002;36 Suppl 1:3-20.
13. Pradat P, Alberti A, Poynard T, Esteban JL, Weiland O, Marcelin P, et al. Predictive value of ALT levels for histologic finding in chonic hepatitis C: a European collaborative study. Hepatology. 2002;36:973-7.